Pegcetacoplan

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 253 publications

Ophthalmology : what's new in 2025

Ophthalmology : what's new in 2025

Journal: Revue medicale suisse

Published: January 22, 2026

Advancing treatment goals for paroxysmal nocturnal hemoglobinuria to align with quality of life improvements in the era of anti-complement therapy

Advancing treatment goals for paroxysmal nocturnal hemoglobinuria to align with quality of life improvements in the era of anti-complement therapy

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: January 12, 2026

Real-world clinical outcomes and treatment response in complement inhibitor experienced and naïve PNH patients prescribed pegcetacoplan in Europe and Canada.

Real-world clinical outcomes and treatment response in complement inhibitor experienced and naïve PNH patients prescribed pegcetacoplan in Europe and Canada.

Journal: Hematology (Amsterdam, Netherlands)

Published: January 02, 2026

Effect of Pegcetacoplan on Aqueous Humor Proteome in Geographic Atrophy: A Prospective Exploration.

Effect of Pegcetacoplan on Aqueous Humor Proteome in Geographic Atrophy: A Prospective Exploration.

Journal: Investigative ophthalmology & visual science

Published: December 05, 2025

Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

Journal: The New England journal of medicine

Published: December 03, 2025

Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGN.

Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGN.

Journal: The New England journal of medicine

Published: December 03, 2025

Integrative Landscape of Dry AMD Pathogenesis, Models, and Emerging Therapeutic Strategies.

Integrative Landscape of Dry AMD Pathogenesis, Models, and Emerging Therapeutic Strategies.

Journal: International journal of molecular sciences

Published: November 21, 2025

Real-World Clinical Usage and Safety Profile of Intravitreal Pegcetacoplan in Age-Related Macular Degeneration-Associated Geographic Atrophy.

Real-World Clinical Usage and Safety Profile of Intravitreal Pegcetacoplan in Age-Related Macular Degeneration-Associated Geographic Atrophy.

Journal: Journal of vitreoretinal diseases

Published: November 20, 2025

Short-Term Changes in Intraocular Pressure Following Intravitreal Injection of Pegcetacoplan.

Short-Term Changes in Intraocular Pressure Following Intravitreal Injection of Pegcetacoplan.

Journal: Journal of vitreoretinal diseases

Published: November 17, 2025

Plain language summary of disease activity and therapeutic response to pegcetacoplan for geographic atrophy identified by deep learning-based analysis of OCT.

Plain language summary of disease activity and therapeutic response to pegcetacoplan for geographic atrophy identified by deep learning-based analysis of OCT.

Journal: Immunotherapy

Published: October 24, 2025

Central retinal vein occlusion following intravitreal injections: a case series highlighting multifactorial risk.

Central retinal vein occlusion following intravitreal injections: a case series highlighting multifactorial risk.

Journal: International journal of retina and vitreous

Published: October 21, 2025

Efficacy of Intravitreal Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy.

Efficacy of Intravitreal Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy.

Journal: Journal of vitreoretinal diseases

Published: October 20, 2025

Showing 1-12 of 253

Last Updated: 02/24/2026